Study identifies biomedical potential of bivalves

January 29, 2019

Shellfish like oysters and mussels have the potential to revolutionize human health research, according to a new paper in Developmental and Comparative Immunology. The study reveals how using bivalves as model organisms offers numerous promising avenues for medical research - from pharmaceutical development to bone regeneration.

"Model systems like mice and flies have been invaluable to biology, but there is no such thing as a model system that can answer all the important questions," said José Fernández Robledo, senior research scientist at Bigelow Laboratory for Ocean Sciences and lead author on the paper. "There is a lot of potential for bivalve research to offer unique insights into new solutions."

One promising application in the study is the development of new techniques for fighting diseases from the flu to cancer. Just like humans, oysters are exposed to bacteria and viruses, but oysters fend off these pathogens without the aid of antibodies, the proteins that mammal immune systems use to attack disease. Clams sometimes contract a contagious cancer, which they can cure themselves of - also without antibodies. Learning more about these unique defense mechanisms could inspire new treatment options for human pathologies and diseases.

"Clams don't have chemotherapy or radiation, and somehow they are able to get rid of cancer," said Fernandez Robledo. "How on earth do they do it? Their strategy can give us clues about how to fight cancer in humans."

Studying immunity in bivalves could also help researchers find an alternative to antibiotics, potent drugs to which pathogens are increasingly becoming resistant. Mimicking the antimicrobial compounds that mussels produce may yield new drugs for humans and livestock, which could provide a much-needed pharmaceutical alternative. The study also identifies that oyster research could also inspire new biomaterials, inform toxicology research, increase understanding of the human microbiome, and improve methods of aiding bone growth and repair.

"Sometimes you find incredible new things when you start comparing different organisms," said Fernandez Robledo. "I believe we will find things here that will translate into discoveries for humans."

Currently, Fernandez Robledo's team is working to develop the molecular tools needed to probe bivalve genomes for the lessons they can offer. Researchers recently sequenced the oyster genome and found it to have 28,027 genes, but they don't yet know what most of these genes do. Developing genetic tools will allow researchers to connect the information contained in the oyster genome to the function of those genes, called the oyster's "phenome."

Adrienne Tracy, study author and 2018 Research Experience for Undergraduates intern at Bigelow Laboratory, recently was able to introduce DNA into oyster blood cells in Fernandez Robledo's biosecure laboratory. This critical step is opening the door for testing hypotheses about the function of specific genes and further exploration using tools like CRISPR/Cas9. Fernandez Robledo also hopes to develop an oyster cell culture that would enable researchers around the world to work from a genetically uniform stock, allowing them to compare results directly.

This research can also benefit the shellfish aquaculture industry. As his team is able to probe the oyster genome further, Fernandez Robledo plans to write recommendations that help guide farmers and hatcheries who want to selectively breed their bivalve stocks for resistance to disease or other characteristics like strong shells and rapid growth.

"Oysters are more than good to eat," Fernandez Robledo said. "This research will allow us to unlock their potential as a model system that helps us innovate and improve human health."
-end-
This study was funded by grants from the Saltonstall-Kennedy Foundation, the National Science Foundation, and the National Institute of Health.

Bigelow Laboratory for Ocean Sciences is an independent, nonprofit research institute on the coast of Maine. Its research ranges from the microscopic life at the bottom of marine food webs to large-scale ocean processes that affect the entire planet. Recognized as a leader in Maine's emerging innovation economy, the Laboratory's research, education, and technology transfer programs are contributing to significant economic growth. Learn more at bigelow.org, and join the conversation on Facebook, Instagram, and Twitter.

Bigelow Laboratory for Ocean Sciences

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.